Physician profile
Bailey L Lee
NPI 1619962461
$8,244.01
in general payments reported to CMS, 2019-2025
20 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,330 · 2020: $186 · 2021: $352 · 2022: $266 · 2023: $508 · 2024: $371 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092 · Education: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.39 |
| Education | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $6,025.42 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $866.22 | 2019-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $257.02 | 2022-2025 | Syfovre |
| Genentech USA, INC. | $256.96 | 2019-2025 | Vabysmo |
| Sun Pharmaceutical Industries INC. | $115.16 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.92 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $112.08 | 2019-2021 | |
| Abbvie INC. | $100.58 | 2022-2025 | |
| Alimera Sciences, INC. | $88.03 | 2019-2024 | Yutiq, Iluvien |
| Oyster Point Pharma, INC. | $52.30 | 2022-2023 | Tyrvaya |
| Alcon Vision LLC | $42.57 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $35.10 | 2019-2023 | |
| Astellas Pharma US INC | $30.63 | 2023 | |
| Travere Therapeutics, INC. | $29.03 | 2019-2023 | Cholbam |
| Axogen | $24.06 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $23.34 | 2023 | Lotemax Sm, Vyzulta |
| Aerie Pharmaceuticals, INC. | $22.25 | 2021 | |
| Shire North American Group INC | $19.40 | 2019 | |
| Kala Pharmaceuticals, INC. | $15.78 | 2019 | |
| Mallinckrodt Enterprises LLC | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.